# Blood pressure variability and mortality in patients admitted with acute stroke in a tertiary care stroke centre (2016–2019): a retrospective cohort study

**Authors:** Mohamed Tawengi, Rizeq F Hourani, Tamader Alyaarabi, Ahmed Adel Elsabagh, Yazan Al-Dali, Rama Ghassan Hommos, Jawaher Baraka, Abdelaziz M Tawengi, Bushra M Abdallah, Ahmad Hatem, Sundus Sardar, Yahia Z Imam, Naveed Akhtar, Muhammad Zahid, Suhail Doi, Mohammed Ibn-Masud Danjuma, Abdelnaser Elzouki

PMC · DOI: 10.1136/bmjopen-2024-095773 · BMJ Open · 2025-05-15

## TL;DR

This study found that greater blood pressure variability in the first 72 hours after stroke admission is linked to higher in-hospital and one-year mortality rates.

## Contribution

The study provides new evidence on the association between blood pressure variability and mortality in acute stroke patients from a diverse population.

## Key findings

- Higher systolic and diastolic blood pressure variability was associated with increased in-hospital mortality.
- The association between blood pressure variability and mortality was also observed at the one-year follow-up.
- The study highlights the need for further research to define optimal blood pressure management strategies in stroke patients.

## Abstract

The influence of short-term variations in blood pressure (BP) in acute stroke on clinical outcomes remains uncertain. Our study explores the relationship between BP variability (BPV) from stroke admission up to 72 hours and in-hospital and 1-year mortality.

Retrospective observational cohort study.

Hamad General Hospital (HGH) a tertiary care stroke centre in Qatar.

2820 participants were initially included. After the exclusion of ineligible subjects, 2554 patients (82.5% male, median age 53±9 years) were included. 893 (34.96%) were from the Middle East and North Africa, 1302 (50.98%) were from South Asia, 258 (10.10%) from Southeast Asia, 9 (0.35%) were from East Asia and 92 (3.60%) were from other regions. Eligible participants were adult patients above 18 years of age who presented with acute ischaemic or haemorrhagic stroke. Excluded individuals were those younger than 18 years, had incomplete data, had transient ischaemic attack (TIA), had severe hypoglycaemia on admission (<3.3 mmol/L) or had a history of chronic kidney disease (CKD).

We measured the BP every 4 hours over 3 days with a total of 18 readings from stroke admission. We then categorised BPV into five (L1–L5) and four (L1–L4) levels for systolic and diastolic BPs, respectively, and evaluated their association with mortality.

There were increased odds of in-hospital mortality with increased systolic and diastolic variability (L2, OR 2.64, 95% CI 1.44 to 4.84; L3, OR 4.20 95% CI 2.14 to 8.24; L4, OR 10.14, 95% CI 4.93 to 20.85; L5, OR 23.18, 95%CI 10.88 to 49.37), (p=0.002 to <0.001) and (L2, OR 1.61, 95% CI 0.96 to 2.69; L3, OR 2.95, 95% CI 1.70 to 5.12 and L4, OR 8.00, 95% CI 4.49 to 14.25), (p=0.071 to <0.001), respectively. This was consistent with 1-year mortality for systolic and diastolic BPs.

In a retrospective cohort of ethnically diverse acute stroke patient population, BPV was significantly associated with both in-hospital and 1-year mortality. Further prospective research is needed to define BPV and establish interventions and management accordingly.

## Linked entities

- **Diseases:** stroke (MONDO:0005098), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Diseases:** cerebral oedema (MESH:D001929), cardiac disease (MESH:D006331), infections (MESH:D007239), disability (MESH:D009069), death (MESH:D003643), Stroke (MESH:D020521), hypertension (MESH:D006973), neurological condition (MESH:D019636), NIHSS (MESH:C538175), Acute (MESH:D000208), Cerebral Hemorrhage (MESH:D002543), anxiety (MESH:D001007), infarct (MESH:D007238), neurological deterioration (MESH:D009422), TIA (MESH:D002546), vessel occlusion (MESH:C536223), major disability (MESH:D004830), bleeding (MESH:D006470), intracranial haemorrhage (MESH:D013345), herniation (MESH:D004677), HGH (MESH:D003428), ischaemic (MESH:D018917), CKD (MESH:D051436), ischaemia (MESH:D007511), Ischemic Stroke (MESH:D002544)
- **Chemicals:** fimasartan (MESH:C558933), caffeine (MESH:D002110), BPV (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12083430/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12083430/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12083430/full.md

---
Source: https://tomesphere.com/paper/PMC12083430